Urologist / Urogynecologist
Arizona Urology Specialists / United Urology Group
Seattle, Washington, United States
Suzette E. Sutherland, MD, MS, URPS - Director of Female Urology, a member of the UW Medicine Pelvic Health Center, and Associate Professor in Urology at the University of Washington in Seattle. Her professional interests are dedicated to the betterment of women’s pelvic health. She is committed to Women’s Global Urological Health Initiatives, as well as national and global advocacy for fellow women in this field of Urology/Urogynecology/Female Pelvic Health, and won an AUA/UCF Humanitarian Grant 2023. She completed her medical degree and urologic training at Case Western Reserve University / University Hospital of Cleveland.. She gained further specialty training in female urology/urogynecology from the Center for Continence Care and Female Urology in Mpls/St. Paul, MN, and from the Institute for Sexual Medicine in Boston. After 10 years with a large multi-specialty urology practice in Mpls/St Paul, she joined the academic community at the University of Washington in Seattle (2013). She has made numerous contributions to the medical literature: presentations, papers, and book chapters on urinary incontinence, pelvic prolapse, and sexual health; and she takes an active role in training future female urologists both at the resident and fellowship level. She serves as a consultant for pharmaceutical and medical device companies. She remains active in associated clinical research through multi-center national and international clinical trials, staying abreast of the newest developments in her field. As an advocate for patients and fellow colleagues, she has worked at the local, state, national and international levels through key leadership positions with the Society of Women in Urology (President 2012-2013), the AUA Urology Care Foundation, the Washington State Urology Society, the Minnesota Urology Society (President 2012-2013) and International Volunteers in Urology (IVUmed) to increase awareness about important urological and workplace diversity issues, and to effect policy that governs both medical care and practice.
Normal & Abnormal Cystoscopic Findings – What is it and what to do?
Wednesday, October 23, 2024
8:30 AM – 9:00 AM EDT
Disclosure(s): No relevant disclosure to display
Wednesday, October 23, 2024
10:10 AM – 10:40 AM EDT
Disclosure(s): No relevant disclosure to display
2 Year Results: Revi™ Therapy, Implanted Neuromodulator for Urgency Incontinence
Thursday, October 24, 2024
3:45 PM – 3:55 PM EDT
Disclosure(s): No relevant disclosure to display